Avaii Wealth Management’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.01M Buy
136,348
+122,911
+915% +$5.82M 1.75% 19
2025
Q4
$684K Buy
13,437
+9,098
+210% +$465K 0.25% 51
2025
Q3
$241K Buy
+4,339
New +$254K 0.09% 131

Other funds holding NVO

Avaii Wealth Management's NVO Position: Q1 2026 in Review

Avaii Wealth Management increased its Novo Nordisk (NVO) stake by 915% in Q1 2026, buying an estimated $5.82M and bringing the position to 136,348 shares worth $5.01M. The position accounts for 1.75% of the portfolio, ranked #19.

Avaii Wealth Management first reported a position in NVO in Q3 2025 and has held it in 3 quarters since. 1,272 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • Avaii Wealth Management held 136,348 shares of Novo Nordisk worth $5.01M as of Q1 2026.
  • Avaii Wealth Management bought 122,911 Novo Nordisk shares in Q1 2026, an estimated $5.82M.
  • Novo Nordisk made up 1.75% of Avaii Wealth Management's portfolio in Q1 2026, its #19 holding.
  • Avaii Wealth Management first reported a position in Novo Nordisk in Q3 2025 and has held it in 3 quarters since.
  • 1,272 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Avaii Wealth Management's 13F filing for Q1 2026, filed 21 Apr 2026.